Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE).
Saved in:
| Title: | Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE). |
|---|---|
| Authors: | Swami N; University of Massachusetts Medical School, Worcester, MA, USA., Hwang WL; Massachusetts General Hospital, Boston, MA, USA; Broad Institute, Cambridge MA, USA., Guo JA; Massachusetts General Hospital, Boston, MA, USA; Broad Institute, Cambridge MA, USA; University of California at San Francisco, San Francisco, CA, USA., Hoffman H; Massachusetts General Hospital, Boston, MA, USA., Abramowitz MC; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Elbakouny Z; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Beltran H; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Chipidza F; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Choueiri T; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Pra AD; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Huang F; University of California at San Francisco, San Francisco, CA, USA., Kaochar S; Baylor College of Medicine, Houston, TX, USA., Kantoff P; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kim DW; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Kishan AU; University of California Los Angeles, Los Angeles, CA, USA., Kobetz E; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Marinac C; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Mucci LA; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Muralidhar V; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Pollack A; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA., Sanford NN; University of Texas Southwestern Medical Center, Dallas, TX, USA., Schaeffer EM; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA., Spratt DE; University of Michigan, Ann Arbor, MI, USA., Zhao SG; University of Michigan, Ann Arbor, MI, USA., Rebbeck TR; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA; Harvard T. H. Chan School of Public Health, Boston, MA, USA., Nguyen PL; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA., Feng FY; University of California at San Francisco, San Francisco, CA, USA., Mahal BA; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, USA. Electronic address: bmahal@med.miami.edu., Alshalalfa M; University of California at San Francisco, San Francisco, CA, USA; Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA. Electronic address: mohamed.alshalalfa@gmail.com. |
| Source: | Cancer genetics [Cancer Genet] 2021 Nov; Vol. 258-259, pp. 61-68. Date of Electronic Publication: 2021 Aug 28. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 101539150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2210-7762 (Print) NLM ISO Abbreviation: Cancer Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
